The Clorox Company (NYSE: CLX) Stock In Prove Me State

The Vanguard Group, Inc. has recently announced that it has increased stake in The Clorox Company (NYSE:CLX) by 0.55%. After grabbing 14.7 million shares, the institutional investor is now in possession of 79979.0 shares of the Consumer Defensive Company. The new investment brought the stake of investor firm to 11.90% having worth around $2.43 billion. Moreover, BlackRock Fund Advisors increased its share by 0.11 million to have a control over 6.46 million shares. And Geode Capital Management LLC raised its holdings to 0.1 million shares by acquiring 2.73 million shares or 2.21% of the stake.

The Clorox Company (CLX) concluded trading on 05/24/23 at a closing price of $159.65, with 1.05 million shares of worth about $167.59 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 6.91% during that period and on Wednesday the price saw a loss of about -0.37%. Currently the company’s common shares owned by public are about 123.65M shares, out of which, 122.88M shares are available for trading.

A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 21 analysts are covering the CLX stock and their offered price forecasts bring an average price target of $156.50. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $186.00 and could fall to a lowest price of $124.00. The stock’s current price level is -3.58% below of average price target set by the analysts, while a dip to estimated low would result in loss of -28.75% for the stock. However, touching the estimated high of $186.00 would mean a gain of 14.17% for the stock.

According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 69 times over the past 12 months. They bought 59,920 shares in 27 of the transactions. In 42 selling transactions, insiders dumped 15,946 shares.

Vanguard Total Stock Market ETF, Vanguard 500 Index Fund, and Vanguard Mid Cap Index Fund are the top 3 mutual funds which are holding stakes in The Clorox Company Vanguard Total Stock Market ETF is currently holding 3.84 million shares of worth totaling $635.69 million. The company recently came buying 17204.0 shares which brought its stake up to 3.11% of the company’s outstanding shares. Vanguard 500 Index Fund bought 15521.0 shares, after which its hold over company’s outstanding shares expand to 2.35%, leaving 2.9 million shares with the mutual fund that have a worth of about $480.18 million. Vanguard Mid Cap Index Fund, after selling 2.88 million shares, have now control over 2.34% of the stake in the company. It holds 1404.0 shares of worth $477.62 million.

The Clorox Company (NYSE: CLX) started trading at $160.78, above $0.53 from concluding price of the previous day. However, the stock later moved at a day high price of 160.78, or with a loss of -0.37%. Stock saw a price change of -4.39% in past 5 days and over the past one month there was a price change of -3.18%. Year-to-date (YTD), CLX shares are showing a performance of 13.77% which increased to 14.37% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $120.50 but also hit the highest price of $178.21 during that period. The average intraday trading volume for The Clorox Company shares is 1.20 million. The stock is currently trading -4.61% below its 20-day simple moving average (SMA20), while that difference is down -1.27% for SMA50 and it goes to 7.31% higher than SMA200.

The Vanguard Group, Inc. acquired 14.7 million shares of The Clorox Company having value of about $2.43 billion. Data submitted at the U.S SEC by The Vanguard Group, Inc. revealed that the firm now holds 79979.0 shares in the company valued at close to $12768647.35, or have control over 0.55% stake in the company. The Clorox Company (NYSE: CLX) currently have 123.65M outstanding shares and institutions hold larger chunk of about 82.20% of that. Holding of mutual funds in the company is about 44.07% while other institutional holders and individual stake holders have control over 50.94% and 38.48% of the stake respectively.

The stock has a current market capitalization of $19.71B and its 3Y-monthly beta is at 0.28. PE ratio of stock for trailing 12 months is 268.77, while it has posted earnings per share of $0.59 in the same period. Its PEG reads 19.55 and has Quick Ratio of 0.50 while making debt-to-equity ratio of 871.33. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CLX, volatility over the week remained 1.51% while standing at 1.93% over the month.

Analysts are in expectations that The Clorox Company (CLX) stock would likely to be making an EPS of $1.14 in the current quarter, while forecast for next quarter EPS is $1.39 and it is $5.69 for next year. For the current quarter EPS, analysts have given the company a lowest target $0.96 which is $1.38 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $0.93 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -33.10% while it is estimated to increase by 24.72% in next year. EPS is likely to grow at an annualized rate of 13.75% for next 5-years, compared to annual growth of -6.90% made by the stock over the past 5-years.

Analysts at 21 brokerage firms have issued recommendations for the The Clorox Company (CLX)’s stock and average of those rates the stock at a “Hold” and assign it a score of 3.50. Out of those 21 Wall Street analysts, 1 recommended a “Buy” rating, while 8 were in favor recommending the stock as a “Hold” and 6 analyst recommended the stock as “Sell”.